Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Larimar Therapeutics, Inc. | Chief Medical Officer | Common Stock | 22.5K | $84K | $3.73 | Jan 17, 2024 | Direct |
Larimar Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 135K | Jan 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LRMR | Larimar Therapeutics, Inc. | Jan 17, 2024 | 2 | $0 | 4 | Jan 19, 2024 | Chief Medical Officer |
LRMR | Larimar Therapeutics, Inc. | Jul 17, 2023 | 1 | $0 | 4 | Jul 18, 2023 | Chief Medical Officer |
LRMR | Larimar Therapeutics, Inc. | Jul 17, 2023 | 0 | $0 | 3 | Jul 18, 2023 | Chief Medical Officer |